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Solution conformational features and interfacial
properties of an intrinsically disordered peptide
coupled to alkyl chains: a new class of peptide
amphiphiles†‡
Antonella Accardo,ab Marilisa Leone,b Diego Tesauro,ab Rosa Aufiero,c
Anaı¨s Be´narouche,c Jean-François Cavalier,c Sonia Longhi,d Frederic Carrierec and
Filomena Rossi*ab
Owing to the large panel of biological functions of peptides and their high specificity and potency, the
development of peptide-based therapeutic and diagnostic tools has received increasing interest. Peptide
amphiphiles (PAs) are an emerging class of molecules in which a bioactive peptide is covalently
conjugated to a hydrophobic moiety. Due to the coexistence in the molecule of a hydrophilic peptide
sequence and a hydrophobic group, PAs are able to self-assemble spontaneously into a variety of
nanostructures, such as monolayers, bilayers, and vesicles. In this work we have synthesized a
disordered peptide, henceforth called R11, and two lipophilic derivatives of R11 bearing two alkyl
chains, connected or not to R11 by an ethoxylic-based linker. The structural properties in solution of
these new PAs were investigated using CD and NMR. R11 lipophilic derivatives display typical features
of PAs, such as the formation of micelles and unilamellar vesicles. In addition, their surface properties
were studied using Langmuir monomolecular films and the results obtained support the formation of
molecular aggregates upon compression of the PA films. The presence of the alkyl chains induces not
only the self-assembly of these new PAs into supramolecular aggregates but also a gain of structure
within the disordered peptide.
1. Introduction
Peptides are the main class of biological macromolecules able
to regulate physiological processes by acting as growth factors,
antibiotics, neurotransmitters, and hormones.1–5 Owing to the
large array of biological functions of peptides and their high
specificity and potency, the development of peptide-based
therapeutic and diagnostic tools has received increasing inter-
est. In this contest, it is customary to replace the definite
peptidic region using organic scaﬀolds with the aim of
developing novel molecular entities that would act as pharma-
cological chaperones.6,7 Numerous endogenous peptides are
natively disordered, i.e. they exhibit a random coil structure in
solution. It is also well known that under diﬀerent physiologi-
cal conditions and biochemical environments, a number of
biological intrinsically disordered peptides misfold and aggre-
gate into well-defined amyloid fibrils, including the b-amyloid
(Ab) peptide associated with Alzheimer’s diseases and the islet
amyloid polypeptide (IAPP) related to type 2 diabetes.8–11
Intrinsically disordered proteins (IDPs) have recently gathered
much interest because of their role in biological processes such
as molecular recognition and their ability to undergo stimulus-
responsive conformational changes.12,13 Overall, the flexibility
of the conformational ensemble of natively disordered proteins
and/or peptides prompts the formation of transient complexes
with binding partners characterized by a low aﬃnity because of
the entropic cost associated with the disorder-to-order transition
upon binding. Interactions with binding partners ultimately
regulate the balance between folding,misfolding and fibrillogenesis,
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thereby modulating the biological activities and proteo-
toxicities of polypeptides.14 The possibility to control the tran-
sition between diﬀerent structural states oﬀers an opening for
employment of IDPs in molecular recognition, biosensor
applications, improvement of therapeutics, and in bio-
nanotechnologies.15,16 A possible route to achieve this goal
consists in anchoring the peptide at supramolecular aggregates
by covalent approaches. Peptide amphiphiles (PAs) are an
emerging class of molecules in which a bioactive peptide is
covalently conjugated to a hydrophobic moiety, commonly one
or two alkyl tails. Supramolecular structures obtained by self-
assembling of PA molecules are characterized by typical
features with respect to traditional surfactant molecules. Due
to the coexistence in the molecule of a hydrophilic peptide
sequence and a hydrophobic tail, they are able to self-assemble
spontaneously into a variety of nanostructures, such as mono-
layers, bilayers, vesicles, elongated worm- or rod-like micelles
or spherical micelles.17–22 Many other PAs form fibers and gels,
composed of elongated micelles, in which bioactive sequences
are perpendicular to their long axis at near van der Waals
density.23 In this spatial arrangement, the peptide moiety
remains at the periphery of the nanostructure, which enables
diﬀerent chemical and biological functionalities including the
ability to allow formation of pores in membranes,24 or to reach
in a selective way a biological target,25 such as membrane
receptors overexpressed by cancerous cells. In all cases, the
peptide availability on nanostructures is not the unique
requirement for receptor binding: a disordered peptide needs
to be able to adopt a specific conformation to assure high
aﬃnity and selectivity in ligand–protein binding processes.26
Moreover, an important design consideration for peptide-based
constructs is the ability of the peptide to retain its function,
which is often correlated with its secondary structure. Small
peptide sequences isolated from parent proteins generally lose
their secondary structure, which can be detrimental to their
activity.27,28 In order to extend the study of PAs, we have herein
synthesized an intrinsically disordered peptide, henceforth
called R11, and two lipophilic derivatives of R11 bearing two
alkyl chains (Fig. 1). Using CD and NMR spectroscopy, we have
investigated the structural properties of this new class of PAs.
Their surface properties were investigated using Langmuir
monomolecular films.
2. Materials and methods
2.1. Chemicals
Protected Na-Fmoc-amino acid derivatives, Rink amide
MBHA resin and coupling reagents were purchased from
Calbiochem-Novabiochem (Laufelfingen, Switzerland). Fmoc-
Tyr[PO(OBzl)OH]-OH was purchased from DBA Italia (Italy).
Fmoc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid
(Fmoc-Ahoh-OH) was purchased from Neosystem (Strasbourg,
France). N,N-Dioctadecylsuccinamic acid was synthesized
according to published methods.29 All other chemicals were
commercially available from Sigma-Aldrich or Fluka (Buchs,
Switzerland) or LabScan (Stillorgan, Dublin, Ireland) and were
used as received unless otherwise stated. Preparative RP-HPLCs
were carried out on a LC8 Shimadzu HPLC system (Shimadzu
Corporation, Kyoto, Japan) equipped with a UV lambda-Max
Model 481 detector using Phenomenex (Torrance, CA) C18 and
C4 (300 Å, 250  21.20 mm, 5 m) columns for R11 peptide and
(C18)2R11 and (C18)2-L1-R11 PAs. Elution solvents are H2O/
0.1% TFA (A) and CH3CN/0.1% TFA (B), from 20% to 95% over
20 minutes at 20 mL min1 flow rate. Purity and identity were
assessed by analytical LC–MS analyses by using Finnigan
Surveyor MSQ single quadrupole electrospray ionization
(Finnigan/Thermo Electron Corporation San Jose, CA), column:
C18/C4-Phenomenex eluted with an H2O/0.1% TFA (A) and
CH3CN/0.1% TFA (B) from 20% to 95% over 20 minutes at
1 mL min1 flow rate.
2.2. Structural predictions
Predictions of secondary structure and structural disorder were
performed by the MeDor metaserver of disorder,17 freely available
at http://www.vazymolo.org/MeDor/index.html.
2.3. Peptide synthesis
The R11 peptide was synthesized by using standard solid-phase
9-fluorenylmethoxycarbonyl (Fmoc) procedures. The Rink amide
MBHA resin (substitution 0.65 mmol g1) was used as the solid-
phase support, and synthesis was performed on a scale of
0.1 mmol. The elongation of peptide was achieved by sequen-
tial addition of Fmoc-AA-OH with PyBOP/HOBt and DIPEA
(1 : 1 : 2) as coupling reagents, in DMF in pre-activation mode.
All couplings were performed twice for 1 hour, by using an
Fig. 1 Schematic representation of (C18)2-R11 and (C18)2-L1-R11 peptide amphiphiles (PAs). The peptide sequence is reported using the one-letter amino acid code.
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excess of 4 equivalents for the single amino acid. To obtain
(C18)2-L1-R11 and (C18)2-R11 peptide amphiphiles (PAs), the
Fmoc-Ahoh-OH derivative and N,N-dioctadecylsuccinamic acid
were coupled as previously described.30 Peptides were fully
deprotected and cleaved from the resin with TFA with 2.5%
(v/v) water and 2.5% (v/v) TIS as scavengers, at room tempera-
ture. The R11 peptide was precipitated with ice-cold ethyl ether,
while PAs were precipitated with water.31
2.4. Preparation of the solutions
All solutions were prepared by weight and simply dissolved in
0.10 M phosphate buﬀer (PBS) at pH 7.4. The pH-meter was
calibrated with three standards at pH 4.00, pH 7.00 and pH
10.00. In most cases the samples to be measured were prepared
from stock solutions. Concentrations of all solutions were
determined by absorbance on a UV-Vis Jasco (Easton, MD)
Model V-5505 spectrophotometer equipped with a Jasco ETC-505T
Peltier temperature controller with a 1 cm quartz cuvette
(Hellma) using a molar absorption coeﬃcient (e267) of
652 M1 cm1 for the phosphorylated tyrosine (pY) residue.32
2.5. Fluorescence measurements
The values of critical micellar concentrations (CMC) of peptide
amphiphiles (C18)2R11 or (C18)2-L1-R11 were obtained by
fluorescence measurements. Fluorescence spectra were recorded
at room temperature on a Jasco Model FP-750 spectrofluoro-
photometer in a 1.0 cm path length quartz cell. Equal excitation
and emission bandwidths were used throughout the experi-
ments, with a recording speed of 125 nm min1 and automatic
selection of the time constant. The CMC were measured by
using 8-anilino-1-naphthalene sulfonic acid ammonium salt
(ANS) as the fluorescent probe.33 Small aliquots of 1  105 M
peptide solution, dissolved in 0.1 M phosphate buﬀer at pH 7.4,
were added to a fixed volume (1.00 mL) of fluorophore
(1  105 M ANS) directly in the quartz cell. CMC values were
determined by linear least-squares fitting of the fluorescence
emission at 480 nm, upon excitation at 350 nm versus the
amphiphile concentration.
2.6. DLS characterization
Dynamic light scattering measurements were carried out using
a Zetasizer Nano ZS (Malvern Instruments, Westborough, MA)
that employs a 1731 backscatter detector. Other instrumental
settings are measurement position (mm): 4.65; attenuator: 8;
temperature 25 1C; cell: disposable sizing cuvette. DLS samples
were prepared at a final concentration of 3  104 M and
centrifuged at room temperature at 13 000 rpm for 5 min.
2.7. Monomolecular film experiments
Surface pressure–molecular area (p–A) isotherms were recorded
for (C18)2R11 and (C18)2-L1-R11 using a KSV 5000 tensiometer
and a Teflon trough (61.0 mm width  345.0 mm length 
1.0 mm height) equipped with a mobile Teflon barrier and
placed inside a thermostated chamber at 25 1C. Surface pressure
was measured using a Wilhelmy plate (perimeter 3.94 cm)
attached to an electromicrobalance connected to a microprocessor
controlling the movements of the mobile barrier. For compres-
sion isotherms, the speed of the barrier was 10 mm min1.
Cycles of compression–decompression isotherms were also
performed at a speed of 10 mm min1, with hold times of
1 and 30 seconds after compression and decompression, respec-
tively. Before each experiment, the trough and the mobile barrier
were thoroughly cleaned with tap water, then gently brushed in
the presence of distilled ethanol, before being washed again with
tap water and finally rinsed with double-distilled water. Any
residual surface active impurity was removed before each assay
by sweeping and suction of the surface.
Before performing compression isotherms, the trough was
filled with either 10 mM Tris buﬀer containing 100 mM NaCl,
21 mM CaCl2 and 1 mM EDTA, or 0.1 M phosphate buﬀer, both
prepared with double-distilled water and adjusted at pH 7.4.
The peptide amphiphile monolayer was then formed by spreading
a solution of (C18)2R11 (58 mL) or (C18)2-L1-R11 (66 mL) at
1 mg mL1 in chloroform, using a Hamilton microsyringe. Ten
minutes after spreading the peptide solution, the compression
of the monolayer (in the gaseous state) was started and surface
pressure recorded. For each pressure, the apparent molecular
area of PA was deduced from the amounts of PA spread at the
surface of the trough and the area covered by the film. All
isotherm data herein presented could be repeated (n = 3) with a
coeﬃcient of variation not exceeding 5%.
2.8. CD measurements
Far-UV CD spectra were recorded from 190 to 260 nm on a Jasco
J-810 spectropolarimeter equipped with a NesLab RTE111
thermal controller unit using a 1 mm quartz cell at 25 1C.
Circular dichroism measurements were carried out on 0.1 M
phosphate solutions containing peptide R11 or peptide amphi-
phile (C18)2R11 or (C18)2-L1-R11 at a concentration of 2 104 M
at pH 7.4. Solutions of peptide were prepared in 0.1 M phos-
phate buﬀer at pH 7.4. Other experimental settings were: scan
speed, 10 nm min1; sensitivity, 50 mdeg; time constant, 16 s;
bandwidth, 1 nm. Each spectrum was obtained by averaging
three scans, and by subtracting contributions from other
species in solution.
2.9. NMR measurements
NMR samples of R11 and (C18)2-L1-R11 were dissolved in
0.10 M sodium phosphate buﬀer at pH 7.4, at a concentration
of B1  103 M in a volume of 600 mL with 5% v/v D2O
(99.98% D, Armar Chemicals, Switzerland). Spectra of (C18)2-R11
were recorded for two diﬀerent samples at the concentrations
of 1.40 103 M and 0.140 103 M respectively (in 600 mL of a
0.10 M sodium phosphate buﬀer at pH 7.4 with 5% v/v D2O).
1D 1H, 2D [1H, 1H] TOCSY (70 ms mixing time)34 and 2D
[1H, 1H] NOESY35 experiments (mixing times: 50, 100, 150, 200
and 300 ms) were acquired at 298 K on a Varian Unity Inova
600 MHz spectrometer equipped with a cold-probe. 2D spectra
were usually recorded with a number of scans ranging from 16
to 64, 128-256 FIDs in t1, 1024 or 2048 data points in t2. Water
suppression was achieved with the DPFGSE (Double Pulsed
Field Gradient Selective Echo) sequence.36 The Varian software
Molecular BioSystems Paper
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VNMRJ 1.1D was implemented to process NMR spectra that
were afterwards analyzed with the software NEASY37 included
in CARA (http://www.nmr.ch/).
Proton resonances were assigned with a standard proce-
dure38 based on comparison of 2D [1H, 1H] TOCSY34 and 2D
[1H, 1H] NOESY.35 Chemical shifts were referenced to the water
signal at 4.75 ppm.
3. Results and discussion
3.1. Peptide selection
The ability of a peptide to fold or not to fold is encoded in its
amino acid sequence.12 Usually the combination of low mean
hydrophobicity and high net charge residues is an important
prerequisite for the absence of compact structure. A peptide
sequence of 20 amino acids in length, enriched in disorder-
promoting amino acids, was conceived and its predicted
disorder was analyzed and confirmed using the MeDor
metaserver.17 After prediction, the initial sequence was shor-
tened so as to get a more drug-like molecule that could be easily
modified from the synthetic point of view and that can enable
future design of peptide libraries. Additionally, a Phe and a Leu
residue were added before the C-terminal Thr amino acid, and
a phosphotyrosine (pY) was added at the N-terminus. The
rationale for adding these bulky residues was to introduce
two possible interaction-prone sites, as hydrophobic and in
particular aromatic residues are frequently used by IDPs to
establish contacts with their partners.39 In order to promote
the formation of stable supramolecular aggregates in water,
two lipophilic derivatives ((C18)2-R11 and (C18)2-L1-R11) were
synthetized (Fig. 1). Both peptide amphiphiles (PAs) were
obtained by introducing two alkyl chains of eighteen carbon
atoms at the N-terminus. Moreover, (C18)2-L1-R11 contains a
unit of 21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid
(AhOh) between the peptide sequence and the hydro-
phobic double-tail with respect to (C18)2-R11. This ethoxylic
moiety used as a spacer/linker confers to the peptide an
increased hydrophilicity and accessibility without modifying
the final charge of the molecule. Moreover the ethoxylic-based
spacer could be useful for future applications, being able to
hide the supramolecular aggregates to the reticulo-endothelial
system.40
3.2. Peptide synthesis and aggregates formulation
The R11 peptide and its lipophilic derivatives ((C18)2-R11 and
(C18)2-L1-R11) were synthesized by solid-phase methods using
Rink-amide MBHA resin as a polymeric support and the Fmoc/
tBu chemistry according to standard SPPS protocols.41 Both
lipophilic derivatives were obtained by coupling N,N-diocta-
decylsuccinamic acid at the free N-terminus. (C18)2-L1-R11
contains a unit of hexaoxaheneicosanoic acid between the
R11 peptide and the alkyl chains with respect to (C18)2-R11.
The products, purified by preparative reverse-phase high-
performance liquid chromatography (RP-HPLC), were isolated
in good yields and their purity was assessed using analytical
HPLC and electrospray ionization mass spectrometry (ESI-MS).
HPLC purification of the R11 peptide was performed in high
yields by a C18 column, according to standard procedures.
Conversely, purification of the lipophilic peptide derivatives
required the use of a C4 column owing to the presence of the
two long alkyl chains. Self-assembling supramolecular aggre-
gates were formed by dissolving the lipophilic derivatives in
0.10 M phosphate buﬀer at pH 7.4.
3.3. Structural characterization
The aggregation properties of the lipophilic peptides were
investigated by fluorescence spectroscopy and dynamic light
scattering (DLS). Apparent critical micellar concentration
(CMC) values were determined by a fluorescence-based method
using ANS as a probe. The fluorescence intensity at 480 nm,
corresponding to the maximum of the spectrum, as a function
of the PA concentration is reported in Fig. 2, where apparent
CMC values can be visualized by the graphical break point. As
reported in Table 1, the apparent CMC values of (C18)2-L1-R11
and (C18)2-R11 (5  105 and 6  105 M, respectively) are
quite similar, thus indicating that the presence of an ethoxilic
linker between the peptide and the alkyl tails does not influ-
ence the formation of aggregates capable of sequestering the
ANS. These values are in good agreement with those previously
reported for double-tailed PAs.42
The mean diameter of the aggregates was assessed by
dynamic light scattering. Measurements were performed at
y = 1731 on self-assembled PAs at a concentration of 2  104 M
in 0.1 M phosphate buﬀer at pH 7.4. The (C18)2-R11 peptide
shows a monomodal distribution, which could be attributed to
aggregated structures with apparent translational diﬀusion
coeﬃcients Dslow (see Fig. 3A and Table 1). Instead, the
Fig. 2 Fluorescence intensity of the ANS fluorophore at 480 nm as a function of
PAs concentration; data are multiplied by a scale factor for a better comparison.
CMC values (5.0  105 and 6.0  105 M) are established from graphical break
points.
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distribution of the (C18)2-L1-R11 peptide is bimodal and domi-
nated by the fast mode (Fig. 3B). For a better comparison
between the two PAs, the correlation functions are reported
in Fig. 3C. The Stokes–Einstein eqn (1) is used to evaluate the
hydrodynamic radius, RH, at infinite dilution
RH ¼ KBT
6pZD0
(1)
where D0 is the translational diﬀusion coeﬃcient at infinite
dilution, KB is the Boltzmann constant, T is the absolute
temperature, and Z is the solvent viscosity. Due to the high
solution dilution (C = 1  104 M) of the systems under study,
we have approximately D B D0, and eqn (1) can be reasonably
used to estimate the hydrodynamic radius of the aggregates.
The mean diameter values obtained for slow and fast modes
(Table 1) are compatible with the formation of large supra-
molecular aggregates (mean diameter of around 184–242 nm)
for both PAs, as well as with small aggregates in the case of
(C18)2-L1-R11 (mean diameter of around 16 nm). The size
of the large molecular aggregates would support the forma-
tion of small unilamellar vesicles/liposomes (SUV, 100 nm
range) as observed with phospholipids. Small molecular
aggregates would rather correspond to the formation of
micelles. Both micelles and liposomes seem therefore to
coexist in the case of (C18)2-L1-R11. Based on the DLS results,
the CMC determination by fluorescence spectroscopy has to be
taken with caution since ANS can also be incorporated in
vesicles.
Table 1 Critical micellar concentration (CMC) values determined by fluorescence and diﬀusion coeﬃcients (D) and hydrodynamic radii (RH) obtained from dynamic
light scattering measurements for the systems studied. The terms fast and slow refer to smaller and larger aggregates, respectively
Systems CMC (mol kg1) Dfast  1011 (m2 s1) Mean diameter (nm) Dslow  1012 (m2 s1) Mean diameter (nm)
(C18)2R11 6.0  105 — — 2.26  0.85 185.663  70.16
(C18)2-L1-R11 5.0  105 3.11  0.79 15.76  4.00 2.02  0.74 243.02  89.28
Fig. 3 DLS spectra of (C18)2-R11 (A) and (C18)2-L1-R11 (B) peptide amphiphiles at a concentration of 1  104 M; (C) intensity correlation functions at y 1731 for
(C18)2-R11 and (C18)2-L1-R11 solutions at 1  104 M.
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3.4. Interfacial properties of PAs
Langmuir films were formed at the air–water interface by
spreading known amounts of (C18)2-R11 or (C18)2-L1-R11 and
variations in surface pressure were recorded upon compression
of the film. The surface pressure–area (p–A) isotherm of the
(C18)2-R11 PA spread on Tris buﬀer pH 7.4 showed an inter-
mediate plateau with the surface pressure remaining constant
while the molecular area decreased, suggesting a collapse of the
PA monolayer (Fig. 4). The collapse parameters (molecular area,
Acoll; surface pressure, Pcoll) were determined at the point of
highest compressibility (C = 0.555 m mN1) estimated from the
compression isotherm43,44 and were found to be Acoll = 64.5 Å
2
and Pcoll = 22.8 mN m
1. The molecular area at collapse fits
with previous data obtained with phospholipids bearing two
C18 chains.44 For instance, dioleoyl-phosphatidylcholine shows
an Acoll of 62.9 Å
2 (Pcoll = 43.5 mN m
1) at pH 5.5 and 59.6 Å2
(Pcoll = 48 mN m
1) at pH 8, while dioleoyl-phosphatidylino-
sitol has an Acoll of 66.2 Å
2 (Pcoll = 42 mN m
1) at pH 5.5 and
62.9 Å2 (Pcoll = 46.5 mN m
1) at pH 8.44 Collapse however
occurred at lower surface pressures in the case of (C18)2-R11 PA
and a further increase in surface pressure upon compression
was observed after the plateau (Fig. 4). This profile suggests
that aggregates of (C18)2-R11 PA are formed above the collapse
point and are further expelled from the interface when the
interfacial area is decreased. As shown in Fig. 4, the apparent
molecular area of (C18)2-L1-R11 was lower under similar con-
ditions and no collapse point was observed. The formation and
solubilization of aggregates seem to be more important in that
case, as suggested by the higher compressibility and thus the
‘‘more liquid’’ nature of the PA film. Micelle formation is
probably the reason for the leakage of (C18)2-L1-R11 molecules
from the monolayer during compression.
Similar experiments were performed with 0.1 M phosphate
buﬀer, pH 7.4 in order to reproduce the buﬀer conditions used
for DLS and NMR experiments. The apparent molecular area of
(C18)2-R11 was still higher than that of (C18)2-L1-R11 (Fig. 5)
but the surface pressure–area isotherm (Fig. 5A) had a distinct
pattern with respect to that obtained with Tris buﬀer (Fig. 4).
No collapse plateau was observed for (C18)2-R11. The apparent
molecular areas of (C18)2-R11 at 24 and 30 mNm
1 (88.5 to 74 Å2,
respectively) were higher than those recorded with Tris buﬀer
(Fig. 4). These findings suggest that part of the peptide moiety
could also be inserted in the monolayer at the air–water
interface. The surface pressure–area isotherms recorded upon
successive cycles of compression–decompression of the
(C18)2-R11 monolayer showed a large and reproducible hysteresis,
indicating that part of (C18)2-R11 transferred to the water sub-
phase upon compression underwent a reversible process with
slow kinetics. A hysteresis, though less marked, was also
observed with (C18)2-L1-R11 (Fig. 5B).
3.5. CD measurements
Circular Dichroism (CD) spectroscopy is broadly used to diag-
nose the presence of secondary structure features in peptides or
proteins. In the last years, CD has been currently employed to
Fig. 4 Surface pressure–area (p–A) isotherms obtained with the (C18)2-R11 and
(C18)2-L-R11 peptide amphiphiles spread at the air–water (Tris buﬀer) interface
at 25 1C. The buﬀer contained 10 mM Tris, 100 mM NaCl, 21 mM CaCl2, 1 mM
EDTA and the pH was adjusted to 7.4. The various phases are indicated by letters
(gaseous state, G; liquid state, L) and the putative collapse point of (C18)2-R11 is
indicated by an arrow.
Fig. 5 Cycles of compression–decompression of (C18)2-R11 (A) and (C18)2-L-
R11 (B) monomolecular films at the air–water (phosphate buﬀer) interface at
25 1C. The pH of the 100 mM phosphate buﬀer was adjusted to 7.4. The numbers
1 (compression)–2 (decompression) and 3 (compression)–4 (decompression)
correspond to the first and second cycles, respectively.
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characterize the morphology of aggregates obtained by PAs as a
function of pH.45 Fig. 6 shows a comparison of the CD spectra
of the R11 peptide and of the PAs at concentrations above their
apparent CMC values (2 104 M). The CD spectrum of the R11
phosphopeptide in PBS presents a negative band centred
at 201 nm, typical of unstructured peptides, thereby confirming
MeDor predictions. In contrast, the CD spectra of PAs
show a large minimum at 218 nm, and a maximum at
198 nm, typical of the presence of b-strands. Since only
the peptide moiety contributes to the signal, these results
suggest that the presence of the alkyl chains induces a disorder
to order transition, and in particular an enrichment in the b
content.
3.6. NMR studies
NMR studies of diﬀerent PAs, conducted in aqueous buﬀer and
in the presence of amphiphilic molecules, such as sodiumdo-
decylsulphate (SDS, anionic) and n-dodecyl phosphatidylcho-
line (DPC, zwitterionic), have previously been reported.46–48
Interestingly, Behanna et al.46 studied nanofibers generated
by mixing together diﬀerent PAs containing alkyl chains linked
at either their N-terminal or C-terminal peptide side, and used
2D [1H, 1H] NOESY experiments35 to prove intermolecular
contacts between diﬀerent PA units. Moreover, Fields48 demon-
strated by CD and NMR techniques that the self-assembly of
PAs could favor the formation of protein-like structural topol-
ogies. In the current work, we used 1D and 2D proton NMR
spectroscopy to investigate the conformational properties in
solution of the R11, (C18)2-L1-R11 and (C18)2-R11 peptides. We
first analyzed the R11 peptide in aqueous buﬀer (0.10 M sodium
phosphate pH 7.4) at a concentration of B1  103 M. Under
these experimental conditions, R11 is highly flexible and lacks
ordered secondary structure elements as indicated by the nearly
complete absence of the signal in the 2D [1H, 1H] NOESY
experiment35 (data not shown). In the case of (C18)2-L1-R11,
we carried out a detailed NMR analysis. High quality NMR
spectra, containing sharp signals, could in fact be recorded in
phosphate buﬀer. We could get resonance assignments for
most of the C18 alkyl tails, linker and peptide protons
(Table S1, ESI‡). Analysis of the 2D [1H, 1H] NOESY spectrum
revealed NOEs between the CH2 groups from the C18 alkyl
chains and peptide protons (Fig. 7, lower panel). Correlations
between these methylene groups at 1.17 ppm (Table S1, ESI‡)
and aromatic protons of Phe and pTyr could be unambiguously
assigned. Strong NOEs arising from correlations between
peptide aromatic protons and CH2 protons of the spacer, which
resonate at 3.55, 3.51, 2.55 and 2.42 ppm, could be identified as
well (Table S1, ESI‡, and Fig. 7, lower panel). As for the peptide
portion of the molecule, sequential NOEs characteristic of
extended conformations could be detected (Fig. 7, upper
panel). According to DLS measurements, the sharpness of the
NMR signals let us speculate that, under the experimental
conditions used to run the NMR experiments, (C18)2-L1-R11
forms small supramolecular aggregates. Besides, our data
indicate that the peptide region does indeed interact with both
the C18 chains and the linker. This scenario is probably favored
by the ethoxylic spacer that interposed between the peptide and
the alkyl chain, confers to (C18)2-L1-R11 a certain degree of
flexibility in solution. This flexibility could promote the inser-
tion of the peptide into the hydrophobic core of (C18)2-L1-R11
aggregates and destabilize the supramolecular packing with a
significant decrease in the aggregation number. This could
explain why both micellar and liposome-like aggregates are
observed with (C18)2-L1-R11 using DLS.
Afterwards, we analyzed by NMR the (C18)2-R11 peptide
(1.4  10–3 M concentration). In this case, formation of aggre-
gates, produced by self-association, is evident in the 2D [1H, 1H]
TOCSY34 and NOESY35 experiments whose sensitivity is
Fig. 6 Far-UV CD spectra of the R11 peptide and of the (C18)2-R11 and (C18)2-L1-R11 peptide amphiphiles at pH 7.4. The concentration of both PAs is 2.0  104 M,
well above the CMC so as to ensure the presence of aggregates in solution.
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reduced by line broadening (Fig. 8). Detailed NMR character-
ization for (C18)2-R11 was not achievable. However, as shown in
Fig. 8, NOEs between the CH2 protons of the C18 alkyl chains
and either peptide HN or aromatic protons appear rather clear
and strong (Fig. 8). Line broadening also aﬀected NMR spectra
recorded on a (C18)2-R11 sample after a ten-fold dilution (final
concentration equal to 0.140  103 M), thus confirming the
high tendency of this PA to self-associate. We can speculate, in
agreement with dynamic light scattering data, that larger
aggregates are formed by (C18)2-R11 with respect to (C18)2-L1-
R11 and that at least a few peptide moieties lie in these
supramolecular systems in a way that enables them to contact
the C18 alkyl chains.
4. Conclusions
PAs have already deserved various investigations but this is the
first time an intrinsically disordered peptide is used as a polar
head connected to alkyl chains. Overall, the physical methods
used in this study allowed us to describe the self-assembly of
(C18)2-R11 and (C18)2-L1-R11 in supramolecular aggregates
compatible with unilamellar vesicles and micelles, respectively
(Fig. 9). The characterization of this new class of PAs by far-UV
CD spectroscopy showed that the high flexibility of the free R11
peptide is reduced in both lipophilic peptides and suggests that
these compounds can undergo some disorder-to-order transi-
tion upon their self-assembly in supramolecular aggregates.
The study of the interfacial behavior of these new PAs by the
Langmuir film technique showed that they are endowed with
features typical of surfactant molecules. These new amphi-
philes have mainly a fundamental interest at this point, but
their supramolecular aggregates presenting an ordered core
and a ‘‘disordered’’ surface might later be used as scaﬀolds for
developing applications in chemistry and medicine. Indeed,
the ability of the alkyl chains to trigger a gain of structure
within the disordered peptide could be used to modulate PA
molecules able to form more sophisticated architectures. These
new PAs could be engineered for applications in the encapsula-
tion of living cells as well as in biomedical engineering and in
biocompatible materials. The design of supramolecular sys-
tems, generated by joining together a disordered peptide and a
lipophilic moiety, could drive the disordered peptide to fold
Fig. 7 (Upper panel) Pattern of sequential NOEs for the (C18)2-L1-R11 peptide.
The one letter amino acid code is used for the diﬀerent residues, y stands for
phosphotyrosine; dAB(i, i + 1) represents a NOE contact between protons HA and
HB of the i and i + 1 amino acids respectively. The thickness of the bars is
proportional to the corresponding peak intensity. The graph has been generated
with Cyana 2.1.49 (Lower panel) Expansion of the 2D [1H, 1H] NOESY 200
spectrum of (C18)2-L1-R11. In the reported region, correlations belonging to
HN and aromatic protons can be observed; the rectangles highlight cross-peaks
between aromatic protons of Phe and pTyr and CH2 protons from the alkyl
terminal chains and linker.
Fig. 8 2D [1H, 1H] NOESY 200 spectrum of the (C18)2-R11 peptide (at 1.40 
103 M concentration in 0.10 M phosphate buﬀer pH 7.4). An expansion
containing peaks arising from HN and aromatic protons is shown. The rectangle
encompasses cross-peaks between CH2 protons of the alkyl chains and peptide
moieties.
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into a stable structure. This structural modification could be a
promising route to develop a new class of bio-molecules for
processes in which a specific conformational rearrangement is
required.
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